## Abstract Genome‐wide association studies, using hundreds of thousands of single‐nucleotide polymorphism (SNP) markers, have become a standard approach for identifying disease susceptibility genes. The change in the technology poses substantial computational and statistical challenges that have b
Analysis of family- and population-based samples in cohort genome-wide association studies
✍ Scribed by Ani Manichaikul; Wei-Min Chen; Kayleen Williams; Quenna Wong; Michèle M. Sale; James S. Pankow; Michael Y. Tsai; Jerome I. Rotter; Stephen S. Rich; Josyf C. Mychaleckyj
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 497 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
With rapid advances in genotyping technologies in recent years and the growing number of available markers, genomewide association studies are emerging as promising approaches for the study of complex diseases and traits. However, there are several challenges with analysis and interpretation of such
## Abstract Genome‐wide association studies have recently identified many new loci associated with human complex diseases. These newly discovered variants typically have weak effects requiring studies with large numbers of individuals to achieve the statistical power necessary to identify them. Lik
Despite the success of genome-wide association studies, much of the genetic contribution to complex human traits is still unexplained. One potential source of genetic variation that may contribute to this “missing heritability” is that which differs in magnitude and/or direction between males and fe
## Abstract An appealing genome‐wide association study design compares one large control group against several disease samples. A pioneering study by the Wellcome Trust Case Control Consortium that employed such a design has identified multiple susceptibility regions, many of which have been indepe
## Abstract Many complex diseases are influenced by genetic variations in multiple genes, each with only a small marginal effect on disease susceptibility. Pathway analysis, which identifies biological pathways associated with disease outcome, has become increasingly popular for genome‐wide associa